In general, nanoparticles have been shown to accumulate in the body, particularly in organs in the gastrointestinal tract, along with the liver, spleen, and capillaries of the lungs.

Titanium dioxide is produced in two main forms. The primary form, comprising over 98 percent of total production, is pigment grade titanium dioxide. The pigmentary form makes use of titanium dioxide’s excellent light-scattering properties in applications that require white opacity and brightness.

Titanium IV oxide is also used in the pharmaceutical industry. It is often used as a coating for medications to improve their stability and appearance. Titanium dioxide helps to protect medications from degradation caused by light, moisture, and other environmental factors. It is commonly used in tablets, capsules, and other oral dosage forms to improve their shelf life and effectiveness.

The market for anatase titanium dioxide has expanded significantly over the years, driven by growing demand from various sectors. Manufacturers are now focusing on optimizing the production processes to enhance the quality and performance of anatase TiO2. This includes advancements in synthesis methods to produce nanoparticles with improved dispersion and stability. Companies are investing in research and development to innovate new applications, particularly in the fields of renewable energy and sustainable materials.

Dawn Polymer Material, a brother company of Dawn Titanium, has successfully applied for an Initial Public Offerings (IPO), which has started rumours about Dawn Titanium is also about to apply for the IPO.